NHI-3/31/2014-10-Q/A


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q/A
(Mark One)
[ x ]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the quarterly period ended March 31, 2014
 
 
[ ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the transition period from _____________ to _____________

Commission File Number 001-10822
National Health Investors, Inc.
(Exact name of registrant as specified in its charter)
Maryland
 
62-1470956
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
222 Robert Rose Drive, Murfreesboro, Tennessee
 
37129
(Address of principal executive offices)
 
(Zip Code)
(615) 890-9100
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ x ] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files) Yes [ x ] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer          [ x ]
 
Accelerated filer                      [ ]
Non-accelerated filer            [ ]
 
Smaller reporting company     [ ]
(Do not check if a smaller reporting company)
 
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [ x ]

There were 33,051,999 shares of common stock outstanding of the registrant as of May 1, 2014.






EXPLANATORY NOTE

This amendment on Form 10-Q/A contains only the cover page, this explanatory note, the signature page and Exhibit 101. The sole purpose of this Amendment to the Registrant’s Quarterly Report on Form 10-Q for the period ended March 31, 2014 (the “10-Q”), as filed with the Securities and Exchange Commission on May 2, 2014, is to include eXtensible Business Reporting Language (XBRL) information in Exhibit 101 that was excluded from the timely filed Original Filing, as provided for under Rule 405 of the SEC’s Regulation S-T. This Amendment does not reflect events or transactions occurring after the date of the Original Filing or modify or update those disclosures that may have been affected by events or transactions occurring subsequent to such filing date, and, except as described above, all information included in the Original Filing remains unchanged.

Exhibit 101 provides the following items formatted in XBRL: (1) Condensed Consolidated Balance Sheets as of March 31, 2014 and December 31, 2013; (2) Condensed Consolidated Statements of Income for the Quarters Ended March 31, 2014 and 2013; (3) Condensed Consolidated Statements of Comprehensive Income for the Quarters Ended March 31, 2014 and 2013; (4) Condensed Consolidated Statements of Equity for the Quarters Ended March 31, 2014 and 2013; (5) Condensed Consolidated Statements of Cash Flows for the Quarters Ended March 31, 2014 and 2013; and (6) Notes to Condensed Consolidated Financial Statements.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
NATIONAL HEALTH INVESTORS, INC.
 
 
(Registrant)
 
 
Date:
May 8, 2014
/s/ J. Justin Hutchens
 
 
J. Justin Hutchens
 
 
President, Chief Executive Officer,
 
 
and Director
 
 
 
Date:
May 8, 2014
/s/ Roger R. Hopkins
 
 
Roger R. Hopkins
 
 
Chief Accounting Officer
 
 
(Principal Financial Officer and Principal Accounting Officer)





Item 6. Exhibits.

Exhibit No.
Description
*101.INS
XBRL Instance Document
 
 
*101.SCH
XBRL Taxonomy Extension Schema Document
 
 
*101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
*101.LAB
XBRL Taxonomy Extension Label Linkbase Document
 
 
*101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
*101.DEF
XBRL Taxonomy Extension Definition Linkbase Document

* As provided in Rule 406T of Regulation S-T, this information shall not be deemed “filed” for purposes of Sections 11 and 12 of the Securities Act and Section 18 of the Securities Exchange Act or otherwise subject to liability under those sections.